Chaum Global Stem Cell Clinical Trials Center

Current Clinical Trials

Various clinical development programs and unmet medical needs are successfully led by cooperative clinical research and development teams

Embryonic Stem Cells Pipelines

Cell Target Diseases
Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells Dry Age-Related Macular Degeneration
Stargardt’s Macular Dystrophy
Myopic Macular Degeneration
Somatic Cell Nuclear Transferred Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cell Dry Age-Related Macular Degeneration

NK Cells

Cell Target Diseases
Autologous Natural Killer Cells Curative Surgery And Adjuvant For Solid Cancer
Epithelial Ovarian Cancer
Glioblastoma
Hepatocellular Carcinoma

Adult Stem Cells Pipelines

Cell Target Diseases
Dendritic Cells Glioblastoma
Cord Stem Cells Ischemic Stroke
Osteoporotic Vertebral Compression Fracture
Herniated Inter Vertebral Disc
Cord Blood Cells Spinal Cord Injury
Traumatic Brain Injury
Alzheimer’s Disease
Cerebral Palsy
Subjective Cognitive Impairment
Progeria
Adipose-Derived Mesenchymal Stem Cells Knee Osteoarthritis
Degeneration Chronic Discogenic Back Pain
Breast Reconstruction
Asherman’s Syndrome
mesenchymal stem cells derived from bone marrow Atopic Dermatitis
Tonsil-Derived Mesenchymal Stem Cells Psoriasis
Neuronal Precursor Cells Parkinson’s Disease
Placenta–Derived Mesenchymal Stem Cells Traumatic Optic Neuropathy
Alzheimer's Disease
Intermittent Claudication